AI assistant
Armata Pharmaceuticals, Inc. — Director's Dealing 2005
Jul 29, 2005
34152_dirs_2005-07-29_a79d7cb0-82ef-4366-90e1-b4f14bca3019.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-19
Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-07-19 | Common Stock, $0.01 Par Value | S | 3700 | $0.80 | Disposed | 12023846 | Indirect |
| 2005-07-19 | Common Stock, $0.01 Par Value | S | 200 | $0.8002 | Disposed | 12023646 | Indirect |
| 2005-07-19 | Common Stock, $0.01 Par Value | S | 6100 | $0.81 | Disposed | 12017546 | Indirect |
| 2005-07-19 | Common Stock, $0.01 Par Value | S | 2000 | $0.82 | Disposed | 12015546 | Indirect |
| 2005-07-20 | Common Stock, $0.01 Par Value | S | 2500 | $0.80 | Disposed | 12013046 | Indirect |
| 2005-07-20 | Common Stock, $0.01 Par Value | S | 2500 | $0.81 | Disposed | 12010546 | Indirect |
Footnotes
F1: This amendment to the Form 4 originally filed on July 21, 2005 (the "Original Form 4") amends and restates the Original Form 4 in its entirety and is being filed solely to correct the amount of Targeted Genetics Corporation common stock beneficially owned by the reporting person. The Original Form 4 inadvertently overreported the reporting person's beneficial ownership of Targeted Genetics Corporation common stock by 25,000 shares.
F2: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.